This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Astrazeneca Ab. Active years: 2005-2008.
Company Filing History:
Years Active: 2005-2008
Title: Kyrre Thalberg: Innovator in Inhalable Pharmaceutical Compositions
Introduction
Kyrre Thalberg is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of respiratory disorders. With a total of 2 patents, Thalberg's work focuses on enhancing the stability and efficacy of inhalable medications.
Latest Patents
Thalberg's latest patents include innovative inhalable pharmaceutical compositions designed for the treatment of respiratory disorders such as asthma, rhinitis, and chronic obstructive pulmonary disease (COPD). These compositions are characterized by their high storage stability and include active ingredients such as formoterol and a corticosteroid. This advancement is crucial for improving patient outcomes and ensuring the effectiveness of inhalable treatments.
Career Highlights
Kyrre Thalberg is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing cutting-edge solutions for respiratory health. Thalberg's dedication to innovation in this field has positioned him as a key figure in pharmaceutical research.
Collaborations
Thalberg has collaborated with esteemed colleagues, including Karin Malmqvist-Granlund and Per-Gunnar Nilsson. These partnerships have fostered a collaborative environment that enhances the development of new and effective pharmaceutical solutions.
Conclusion
Kyrre Thalberg's contributions to inhalable pharmaceutical compositions reflect his commitment to improving respiratory health. His innovative patents and collaborations with industry experts underscore his role as a significant inventor in the pharmaceutical field.